Диагностика неалкогольной жировой болезни печени в современной клинической практике

1. Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtrans Gastrointestinal and liver disease.10th edition. 2015.
2. Mayo Clinic gastroenterology and hepatology board review. Editor-in-chief S.C.Hauser; associate editors A.S.Oxentenko, W.Sanchez. 5th edition. 2015.
3. Маев И.В., Кузнецова Е.И., Андреев Д.Н., Дичева Д.Т. Современные и перспективные подходы к диагностике неалкогольной жировой болезни печени. Consilium Medicum. 2015; 17 (8): 20–7.
4. Park S, Jeon WK, Kim SH et al. Prevalence and risk factors of nonalcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006; 21: 138–43.
5. Fan JG, Farrell GC. Epidemiology of nonalcoholic fatty liver disease in China. J Hepatol 2009; 50: 204–10.
6. Hashimoto E, Tokushigie K. Prevalence, gender, ethnic variation, and prognosis of NASH. J Gastroenterol 2011; 46: 63–9.
7. Wong VW, Chu WC, Wong GL et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012; 61 (3): 409–15.
8. Ivashkin V, Drapkina O. The prevalence of non-alcoholic fatty liver disease in Russian Federation. Gut 2009; 58: 1207.
9. Маев И.В., Андреев Д.Н., Дичева Д.Т. и др. Неалкогольная жировая болезнь печени: современное состояние проблемы. Мед. вестн. МВД. 2012; 61 (6): 35–40.
10. Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol 2014; 5 (3): 211–8.
11. Torres DM, Williams CD, Harrison SA. Features, diagnosis and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012; 10: 837–58.
12. Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin Liver Dis 2004; 24: 349–62.
13. Маев И.В., Андреев Д.Н. Неалкогольная жировая болезнь печени: механизмы развития, клинические формы и медикаментозная коррекция. Consilium Medicum. Гастроэнтерология (Прил.). 2012; 2: 36–9.
14. Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol 2015; 7 (11): 1450–9.
15. Law K, Brunt EM. Nonalcoholic fatty liver disease. Clin Liver Dis 2010; 14: 591–604.
16. Brunt EM, Tiniakos DG. Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16: 5286–96.
17. Harmon RC, Tiniakos DG, Argo CK. Inflammation in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol 2011; 5: 189–200.
18. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313–21.
19. Bedossa P, Poitou C, Veyrie N et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 2012; 56: 1751–9.
20. Богомолов П.О., Павлова Т.В. Неалкогольный стеатогепатит: патофизиология, патоморфология, клиника и подходы к лечению. Фарматека. 2003; 10.
21. Маев И.В., Абдурахманов Д.Т., Андреев Д.Н., Дичева Д.Т. Алкогольная болезнь печени: пособие для врачей. М.: Форте Принт, 2014.
22. Dvorak K, Stritesky J, Petrtyl J et al. Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice – an exploratory case-control study. PLoSOne. 2014; 9 (10): e111551.
23. Machado MV, Cortez-Pinto H. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatology 2013; 58: 1007–19.
24. Saadeh S, Younossi ZM, Remer EM et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745–50.
25. Fierbinteanu-Braticevici C, Dina I, Petrisor A et al. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol 2010; 16: 4784–91.
26. Mazhar SM, Shiehmorteza M, Sirlin CB. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 2009; 7: 135–40.
27. Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705–13.
28. Bonder A, Afdhal N. Utilization of Fibro Scan in clinical practice. Curr Gastroenterol Rep 2014; 16 (2): 372.
29. Carey E, Carey WD. Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete? Cleve Clin J Med 2010; 77 (8): 519–27.
30. Ebinuma H, Saito H, Komuta M et al. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with FibroScan®. J Gastroenterol 2011; 46: 1238–48.
31. Rustogi R, Horowitz J, Harmath C et al. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 2012; 35: 1356–64.

Е.И.Кузнецова, Д.Н.Андреев

ГБОУ ВПО Московский государственный медико-стоматологический университет им. А.И.Евдокимова Минздрава России